PacBio CEO steps down as Q2 loss widens Read more →
Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trial Read more →
Tarsus pays $450M for Alkeus and its phase 3-stage retinal disease drug Read more →
Contract Director
